YEVGENIY KHARITON to Sodium-Glucose Transporter 2
This is a "connection" page, showing publications YEVGENIY KHARITON has written about Sodium-Glucose Transporter 2.
Connection Strength
0.193
-
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021 11; 27(11):1954-1960.
Score: 0.193
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.